Your session is about to expire
← Back to Search
Phototherapy
Open Label Narrowband UVB phototherapy for Psoriasis
N/A
Recruiting
Research Sponsored by Psoriasis Treatment Center of Central New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Psoriasis area severity index score
Secondary outcome measures
Body Surface Area
Physician's Global Assessments multiplied by Body surface area
Physicians Global Assessment
Trial Design
1Treatment groups
Experimental Treatment
Group I: Open Label Narrowband UVB phototherapyExperimental Treatment1 Intervention
Open Label Narrowband UVB phototherapy for 12 weeks.
Find a Location
Who is running the clinical trial?
Psoriasis Treatment Center of Central New JerseyLead Sponsor
14 Previous Clinical Trials
412 Total Patients Enrolled
13 Trials studying Psoriasis
372 Patients Enrolled for Psoriasis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger